Family-centered Tai Chi exercise for lung function and mental health after lung surgery
Vice Superintendent
This study tests if an eight-week family-centered Tai Chi exercise program can help improve lung function and mental health in people recovering from lung cancer surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | China Medical University Hospital Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Taichung, North Dist.) |
| Trial ID | NCT06104774 on ClinicalTrials.gov |
What this trial studies
This study explores the effects of an eight-week family-centered Tai Chi exercise program on lung function and mental health in patients recovering from thoracoscopic surgery for lung cancer. The research aims to address the decline in lung function and the psychological burden experienced by patients and their caregivers post-surgery. Participants will be divided into an experimental group, which will engage in Tai Chi exercises, and a control group receiving standard treatment. The study will utilize a quasi-experimental design with repeated measures analysis to evaluate outcomes.
Who should consider this trial
Good fit: Ideal candidates include patients who have undergone thoracoscopic lobectomy or similar procedures and are classified as ASA I-II.
Not a fit: Patients requiring chemotherapy or radiation therapy, or those with significant physical impairments, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve lung function and mental health outcomes for patients recovering from thoracoscopic surgery.
How similar studies have performed: While Tai Chi has shown promise in enhancing lung function and mental health in other contexts, this specific application post-thoracoscopic surgery is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Hospitalized to receive thoracoscopic lobectomy, wedge/partial resection, lobectomy, or sleeve resection. 2. American Society of Anesthesiologists (ASA) physiological status classification I-II (ASA, 2019).ASA Physical Status Class I: A healthy person who is healthy and does not smoke or drink.ASA physical status class II: People with mild chronic diseases but no substantial functional limitations. 3. Those who can walk on their own without any impairment in limb movement. 4. Able to communicate in Chinese or Taiwanese. Exclusion Criteria: 1. Individuals requiring chemotherapy and radiation therapy for malignant tumors. 2. Those who have practiced Tai Chi, Qigong, external elixir exercises, or pulmonary exercises within the past year. 3. Anticipating hospitalization or surgical treatment within the next three months. 4. Individuals with musculoskeletal or peripheral vascular diseases. 5. Individuals with visual impairment, intellectual disabilities, or memory loss.
Where this trial is running
Taichung, North Dist.
- China Medical University — Taichung, North Dist., Taiwan (Recruiting)
Study contacts
- Principal investigator: Hsing-Chi Hsu, Ph.D — HungKuang University, Taiwan
- Study coordinator: Hsin-Yuan Fang, Ph.D
- Email: fanghy@cmuh.org.tw
- Phone: 04-22052121
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.